EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The value of contrast-enhanced ultrasound in percutaneous biopsy of retroperitoneal masses

Ehsan Safai Zadeh iD, Mathis Görg, Christian Görg, Helmut Prosch iD, Corinna Trenker iD, Christina Carolin Westhoff, Christoph F Dietrich iD, Nils Raab, Amjad Alhyari iD, Katharina Huber, Svitlana Pochepnia, Michael Weber und 1 weitere

Ultraschall in der Medizin - European Journal of Ultrasound · 01.02.2025 · 46 (01) · 66-72

DOI: 10.1055/a-2282-2353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ultraschall in der Medizin - European Journal of Ultrasound, erschienen am 01.02.2025. Verfasst von Ehsan Safai Zadeh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Wien, Austria. Hauptthemen laut MEDLINE: Retroperitoneal Neoplasms, Contrast Media, Ultrasonography, Interventional, Image-Guided Biopsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the diagnostic yield of contrast-enhanced ultrasound (CEUS)-guided biopsy of retroperitoneal masses (RMs). Materials and Methods Between 2006 and 2023, 87 patients presented at our US center for biopsy of an RM. In all biopsies, CEUS was performed prior to the intervention. The technical success rate of biopsy, the presence of diagnostic tissue in solid tumor biopsy samples, the accuracy of the biopsy and the occurrence of post-interventional complications were evaluated.

Results

A US-guided biopsy could be conducted in 84/87 cases (96.6%). In 3/87 cases (3.4%), US-guided biopsy was impossible because the planned needle path was obstructed by vital structures. Of 84 lesions, 80 (95.2%) were solid lesions, and 4 (4.8%) were lesions containing fluid. In all solid tumors, 80/80 (100%), diagnostic vital tissue was successfully obtained. CEUS-guided biopsy showed a sensitivity of 93.2%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 72.2%, and a diagnostic accuracy of 94.2% for the differentiation between malignant and benign RMs. In one of the 84 cases (1.2%), there was a complication of postinterventional abdominal pain.

Conclusion

Percutaneous CEUS-guided biopsy is a safe procedure with a high diagnostic yield and a low complication rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retroperitoneal NeoplasmsContrast MediaUltrasonography, InterventionalImage-Guided BiopsyImage EnhancementHumansFemaleMaleMiddle AgedAgedAdultSensitivity and SpecificityRetroperitoneal SpaceAged, 80 and overYoung AdultAdolescentUltrasonographyDiagnosis, DifferentialPhospholipidsSulfur Hexafluoride

Substanzen

Contrast Mediacontrast agent BR1PhospholipidsSulfur Hexafluoride

Autor:innen und Institutionen

  • Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Wien, Austria.
  • Interdisciplinary Centre of Ultrasound Diagnostics, Gastroenterology, Endocrinology, Metabolism and Clinical Infectiology, University Hospital of Giessen and Marburg Campus Marburg, Marburg, Germany.
  • Haematology, Oncology and Immunology, University Hospital of Giessen and Marburg Campus Marburg, Marburg, Germany.
  • Institute of Pathology, University Hospital of Giessen and Marburg, Campus Marburg, Philipps-University of Marburg, Marburg, Germany.
  • Department General Internal Medicine, Kliniken Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland.
  • General internal medicine and gastroenterology, Westmecklenburg Klinikum Helene von Bulow GmbH, Ludwigslust, Germany.

ORCID-Profile: Ehsan Safai Zadeh, Helmut Prosch, Corinna Trenker, Christoph F Dietrich, Amjad Alhyari, Hajo Findeisen

Zitieren

APA

Safai Zadeh, E., Görg, M., Görg, C., Prosch, H., Trenker, C., Westhoff, C. C., Dietrich, C. F., Raab, N., Alhyari, A., Huber, K., Pochepnia, S., Weber, M., & Findeisen, H. (2025). The value of contrast-enhanced ultrasound in percutaneous biopsy of retroperitoneal masses. Ultraschall in der Medizin - European Journal of Ultrasound, 46(01), 66-72. https://doi.org/10.1055/a-2282-2353

Vancouver

Safai Zadeh E, Görg M, Görg C, Prosch H, Trenker C, Westhoff CC, et al. The value of contrast-enhanced ultrasound in percutaneous biopsy of retroperitoneal masses. Ultraschall in der Medizin - European Journal of Ultrasound. 2025;46(01):66-72. doi:10.1055/a-2282-2353

BibTeX
@article{SafaiZadeh2025,
  author = {Safai Zadeh, Ehsan and Görg, Mathis and Görg, Christian and Prosch, Helmut and Trenker, Corinna and Westhoff, Christina Carolin and Dietrich, Christoph F and Raab, Nils and Alhyari, Amjad and Huber, Katharina and Pochepnia, Svitlana and Weber, Michael and Findeisen, Hajo},
  title = {The value of contrast-enhanced ultrasound in percutaneous biopsy of retroperitoneal masses},
  journal = {Ultraschall in der Medizin - European Journal of Ultrasound},
  year = {2025},
  volume = {46},
  number = {01},
  pages = {66--72},
  doi = {10.1055/a-2282-2353}
}
Kostenlos starten →